Abbott Laboratories news

   Watch this stock
Showing stories 11 - 20 of about 107   

Articles published

ABT 43.60 +0.19 (0.44%)
price chart
Abbott Laboratories (NYSE:ABT) Updates On AlereInc (NYSE:ALR), St. Jude ...
Abbott Laboratories (NYSE:ABT) has given updates regarding its $5.80 billion and $25 billion deals with Alere Inc (NYSE:ALR) and St. Jude Medical, Inc. (NYSE:STJ), respectively, during a conference call that followed its second quarter earnings report ...
Oasis Petroleum Inc. (NYSE:OAS) & Abbott Laboratories (NYSE:ABT) Stocks in the ...
On Friday, Shares of Oasis Petroleum Inc. (NYSE:OAS) lost -3.23% to $8.10. The share price is trading in a range of $7.99 - $8.50.
FTC requests more info on Abbott Laboratories' acquisition of St. Jude Medical
The Federal Trade Commission has requested additional information from Chicago-based Abbott Laboratories regarding its decision to acquire St. Jude Medical in St. Paul, Minn.
Abbott Laboratories: Analyst Recommendations before 2Q16 Results  Market Realist
Health Canada Approves Abbott Laboratories (NYSE:ABT) Absorb Heart Stent  Market Exclusive
Abbott Laboratories's Valuation before Its 2Q16 Results
Abbott Laboratories (ABT) is set to release its fiscal 2Q16 results on July 20, 2016. In a Bloomberg survey of 22 brokerage companies on July 13, ~68% of these analysts rated Abbott Laboratories as a “buy” and 32% rated it as a “hold.” None of the ...
Monday Session Roundup For Abbott Laboratories (NYSE:ABT)
Abbott Laboratories (NYSE:ABT) closed at $43.41 after seeing 11451800 shares trade hands during the most recent session. This represents a change of 0.56% from the opening.
Alere keeps giving Abbott Labs more reasons to want out
It's been a rough few months since the maker of medical tests for malaria and strep throat agreed to sell itself to Abbott Labs for $8.4 billion including debt. Alere was already the subject of an SEC inquiry at the time the Abbott deal was inked in ...
Alere's Device Recall Stirs More Questions About Abbott Deal  Bloomberg
Analyst Recommendation Worth Stating Today: Abbott Laboratories (NYSE:ABT)
Abbott Laboratories (NYSE:ABT) went up +0.30% during trading on 7/22/2016, hitting $43.26. The stock had a trading volume of 10.2 M shares.
Twelve Months Forecasted Target Prices set by Analysts: Abbott Laboratories ...
Abbott Laboratories (NYSE:ABT) negotiated 11.53 million shares against it an average volume of 11.65 million shares. The stock concluded the recent trade at $43.41 with upbeat trend move of +0.56%.
Stock Slipping Lower This Year Abbott Laboratories (NYSE:ABT)
Investors in Abbott Laboratories (NYSE:ABT) stock continue to shudder this year as the stock has been unable to gain any traction.
Jefferies Maintains Abbott Laboratories to Buy with Price Target $49.00
Brokerage firm Jefferies Maintains its rating on Abbott Laboratories(NYSE:ABT). In a research note issued to the investors, the brokerage major Raises the price-target to $49.00 per share.